Francis Lo sold $2.2M of ADPT
Chief People Officer at Adaptive Biotechnologies Corp. 95,842 shares at an average of $22.51, traded Jul 1, 2026, filed Jul 6, 2026.
Score components
- +15RoleOfficer
- +25Trade size$2.2M at market
- +10Share of holdings soldSold 33% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001780660-26-000017, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +3,500 | $7.80 | $27k | 254,434 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +3,300 | $12.14 | $40k | 257,734 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +12,206 | $8.46 | $103k | 269,940 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +4,688 | $3.99 | $19k | 274,628 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +14,064 | $8.12 | $114k | 288,692 | Jul 6, 2026 |
| Jul 1, 2026 | SOpen-market sale Common Stock10b5-1 | -8,743 | $22.18 | $194k | 279,949 | Jul 6, 2026 |
| Jul 1, 2026 | SOpen-market sale Common Stock10b5-1 | -42,261 | $22.50 | $951k | 237,688 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Common Stock10b5-1 | +12,626 | $7.80 | $98k | 250,314 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Common Stock10b5-1 | +12,600 | $12.14 | $153k | 262,914 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Common Stock10b5-1 | +12,637 | $8.46 | $107k | 275,551 | Jul 6, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock10b5-1 | -44,838 | $22.59 | $1.0M | 230,713 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,500 | $0.00 | $0 | 72,000 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,300 | $0.00 | $0 | 168,523 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,206 | $0.00 | $0 | 72,859 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -4,688 | $0.00 | $0 | 81,265 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -14,064 | $0.00 | $0 | 126,584 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,626 | $0.00 | $0 | 59,374 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,600 | $0.00 | $0 | 155,923 | Jul 6, 2026 |
| Jul 2, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,637 | $0.00 | $0 | 60,222 | Jul 6, 2026 |
Related signals
Other insiders at Adaptive Biotechnologies Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $948k 35,643 shares | -9% | |
| 22Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $193k 6,444 shares | -2% | |
| 22Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $758k 26,792 shares | -11% | |
| 25Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $1.0M 35,643 shares | -9% | |
| 23Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $3.2M 115,406 shares | -34% | |
| 8Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $32k 1,195 shares | -0% | |
| 48Moderate | Adaptive Biotechnologies Corp | Katey Einterz Owen director | $250k 9,615 shares | -11% | |
| 46Moderate | Adaptive Biotechnologies Corp | Robert Hershberg director | $748k 30,664 shares | -40% | |
| 50Moderate | Adaptive Biotechnologies Corp | Peter M Neupert director | $3.1M 124,690 shares | -49% | |
| 55Moderate | Adaptive Biotechnologies Corp | Chad M Robins CEO and Chairman | $15M 600,000 shares | -24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.